This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Arthur Fridman: Innovator in Antigenic Glycoprotein Research
Introduction
Arthur Fridman is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigenic glycoproteins. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Arthur Fridman holds a patent for "Antigenic Glycoprotein E Polypeptides, Compositions, and Methods of Use Thereof." This patent reflects his expertise and dedication to advancing scientific knowledge and medical treatments. He has 1 patent to his name, highlighting his role as an inventor in this specialized area.
Career Highlights
Fridman is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His position allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His career is marked by a commitment to innovation and excellence in the field of biotechnology.
Collaborations
Throughout his career, Arthur has collaborated with talented professionals, including Jennifer Dawn Galli and Lan Zhang. These partnerships have contributed to the advancement of research and the successful development of new technologies.
Conclusion
Arthur Fridman's contributions to the field of antigenic glycoproteins exemplify the impact of dedicated inventors in the healthcare industry. His work continues to inspire future innovations and advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile